W Bohle

Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice

Gastric cancer

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration

Prognostic significance of T-cell infiltrates, expression of β2-microglobulin and HLA-DR antigens in breast carcinoma

Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer

Active Specific Immunotherapy Against Adenocarcinomas

Active specific immunotherapy with Newcastle-diseasevirus-modified autologous tumor cells following resection of liver metastases in colorectal cancer

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2cm

Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens

Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity

DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST

Cardiac Sarcoidosis

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

Hepatic resection for metastases from colorectal carcinoma — A survival analysis

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

The tumor microenvironment and its role in promoting tumor growth

The immune contexture in human tumours: impact on clinical outcome

Gastric cancer

Lymphocyte infiltrates as a prognostic variable in female breast cancer

In situ hybridisation and S1 mapping show that the presence of infiltrating plasma cells is associated with poor prognosis in breast cancer

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Newcastle disease virus selectively kills human tumor cells

In situ cytokine production by breast cancer tumor-infiltrating lymphocytes

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu-Transgenic Mice

Oncolytic Newcastle Disease Virus for Cancer Therapy: Old Challenges and New Directions

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention

Resection of colorectal liver metastases

Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer

Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent newcastle disease virus

Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival

Predominant Myocardial Sarcoidosis

Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions

Endosonographic tumor staging for treatment decision in resectable gastric cancer.

Contrast-Enhanced Ultrasound (CEUS) for Differentiating Between Hepatocellular and Cholangiocellular Carcinoma